Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States

Abstract
(2012). Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States. Journal of Medical Economics: Vol. 15, No. 2, pp. 264-275. doi: 10.3111/13696998.2011.644645

This publication has 16 references indexed in Scilit: